SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassaysArticle Published on 2022-12-012022-11-15 Journal: Diagnostic microbiology and infectious disease [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] anti-N antibody anti-RBD anti-S2 Anti-spike antibodies antibody Antibody profile Antigen average Cohort demonstrated exhibited HCW healthcare worker IgG immune immunoassay individual Infection infection cohort mRNA vaccines multiplex natural infection Patient positive produced reactivity SARS-CoV-2 SARS-CoV-2 antibody semi-quantitative Support target vaccinated individual vaccination vaccination. [DOI] 10.1016/j.diagmicrobio.2022.115803 PMC 바로가기
The associations between COVID-19 vaccination and psychological disorders among healthcare workers in ChinaArticle Published on 2022-12-012022-11-16 Journal: Journal of affective disorders [Category] COVID19(2023년), SARS, 치료기술, [키워드] adverse event analyzed Anxiety association caused China collected conducted Coverage COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional DASS-21 Depression Factor healthcare healthcare worker incidence Logistic regression mean score nonparametric test participant Prevalence Psychological psychological disorder Psychological state Public Health Agency scored significantly higher significantly lower Sociodemographic characteristics Stress Stress Scale subgroups suffered the mean vaccination vaccination rate vaccination. Vaccines [DOI] 10.1016/j.jad.2022.08.080 PMC 바로가기
The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study단일 의료 시스템에서 의료 종사자들 사이에서 BNT162b2 백신 접종 후 SARS-CoV-2 스파이크 단백질에 대한 부작용과 면역 반응 사이의 연관성: 전향적 관찰 코호트 연구Observational Study Published on 2022-11-302022-09-12 Journal: Human vaccines & immunotherapeutics [Category] MERS, SARS, 임상, 진단, [키워드] administration Adverse Adverse reaction Anti-spike IgG antibody anti-spike IgG level Antibody titer association Asthma BNT162b2 BNT162b2 vaccine conducted COVID-19 Cutoff determine Factor first dose healthcare healthcare worker help humoral humoral immune response Humoral response IgG IgG level immune response information Local majority median median age mRNA mRNA vaccine of BNT162b2 participant Participants prospective observational cohort reaction recipients recruited reported SARS-CoV-2 anti-spike IgG SARS-CoV-2 spike protein second dose significantly higher systemic adverse reactions Systemic adverse reactions. systemic reaction vaccination Vaccine was collected were measured with COVID-19 women [DOI] 10.1080/21645515.2022.2048559 PMC 바로가기 [Article Type] Observational Study
Intention to participate in COVID-19 vaccine clinical trials in May 2021: a cross-sectional survey in the general French populationArticle Published on 2022-11-302022-11-16 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval adjusted Attitude Attitudes Clinical research clinical trial conducted contribute COVID 19 COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional cross-sectional survey Factor female gender France French Government Health healthcare worker immunization increase in Intention media new SARS-CoV-2 Participation predict reduction in risk severe COVID-19 Trial trial. vaccination Vaccine vaccine availability variant [DOI] 10.1080/21645515.2022.2072630 PMC 바로가기
Demographic, behavioural and occupational risk factors associated with SARS-CoV-2 infection in UK healthcare workers: a retrospective observational studyArticle Published on 2022-11-072022-11-15 Journal: BMJ Open [Category] SARS, 변종, 진단, [키워드] 95% CI Analysis assessment behavioural COVID-19 demographic Diseases effective enhanced enrolled Epidemiology Factor General population HCW HCWs Health healthcare Healthcare system healthcare worker higher risk highest hospital identify include Infection infection control investigated Logistic regression measure multivariate logistic regression Observational cohort study occupational Pandemics Personal protective equipment Physiotherapist positive PPE Public public health. questionnaire Regression model Reporting Resilience retrospective risk risk factor risk reduction SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 variant Selection Shrinkage social distancing social distancing measures stability sustained Vaccine variable was used Workplace [DOI] 10.1136/bmjopen-2022-063159 PMC 바로가기
Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022Article Published on 2022-11-012022-11-15 Journal: Eurosurveillance [Category] SARS, 변종, 진단, [키워드] Breakthrough infection dose evaluated HCW healthcare worker Infection infections neutralising neutralising antibody neutralising antibody titre omicron Omicron variants, neutralising antibodies SARS-CoV-2 SARS-CoV-2. uninfected vaccinated individual vaccinated individuals Vaccine variant variants wild type [DOI] 10.2807/1560-7917.ES.2022.27.44.2200785 PMC 바로가기
Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal StudyArticle Published on 2022-11-012022-11-16 Journal: Annals of laboratory medicine [Category] SARS, 변종, [키워드] acute respiratory syndrome analyzed anti-S antibody BNT162b2 BNT162b2 mRNA ChAdOx1 collected Concentration coronavirus Coronavirus disease-19 COVID-19 delta variant demonstrated dose doses Effectiveness Efficacy eight healthcare worker help immunogenicity longitudinal NAbs Neutralizing neutralizing antibody occurred omicron outbreak pandemic predicted produced Prospective PROTECT reached regimen risk second dose study period the vaccine Three-dose vaccination. university hospital vaccination vaccination rate variant variants of concern Wuhan-Hu-1 [DOI] 10.3343/alm.2022.42.6.688 PMC 바로가기
Sars-Cov-2 exposures of healthcare workers and acquisition of COVID-19Comment Published on 2022-11-012023-07-10 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), [키워드] bias Case-control COVID-19 exposures healthcare worker Personal protective equipment Risk factors SARS-CoV-2. [DOI] 10.1016/j.cmi.2022.07.012 PMC 바로가기 [Article Type] Comment
A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospitalArticle Published on 2022-11-012022-11-15 Journal: The Journal of Infection [Category] SARS, 진단, [키워드] 95% CI accounted age analysed Asian assistant Bame black conducted COVID-19 Factor Factors Fever group HCW HCWs healthcare healthcare worker Healthcare workers heterogeneous higher risk hospital immunoassay Increased increased risk independent multivariable model multivariate logistic regression positive Prospective Study reported risk risk factor risk factor analysis SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection sense of taste sero-epidemiology. Seroprevalence Sex significantly significantly higher staff Symptom Symptoms tested [DOI] 10.1016/j.jinf.2022.08.030 PMC 바로가기
Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in JapanArticle Published on 2022-11-012022-11-15 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 진단, [키워드] 95% confidence interval 95%CI adjusted odds ratio age analyzed anti-spike antibody Antibody Response BNT162b2 BNT162b2 mRNA booster vaccination Booster vaccine Cohort Coverage COVID-19 decrease dose Effectiveness eight Factor group groups HCW HCWs Health care worker healthcare worker Increased infection control interquartile range introduced IQR Japan median mRNA vaccine mRNA vaccine. multivariate logistic regression no significant difference not significant positive risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections subject university vaccination Vaccine waning immunity [DOI] 10.1016/j.jiac.2022.07.010 PMC 바로가기